(http://www.in3london.com)

Elsevier Business Intelligence, the medtech industry's leading

provider of strategic partnership and investment conferences,

announces an outstanding roster of presenting senior global investors

for its 'IN3Medical Device 360 London' medical technology investment

and partnering conference, being held April 25-26, 2012, at the

Millennium Gloucester Hotel & Conference Centre, London Kensington.

'IN3 Medical Device 360 London' will feature presentations by

approximately two dozen early-, mid- and late-stage start-up companies

from around the world seeking funding and/or strategic partnership,

developing innovative new technologies in the areas of cardiovascular

biomaterials, cartilage repair, cancer staging, nanotechnology,

neurostimulation, infection control, diagnostics, laparoscopic surgery

and much more. Presenting companies to date include: AiMedics,

Anethon, CellCoTec, Endomagnetics, Enox BioPharma, Implandata

Ophthalmic Products, N8 Medical, NUUBO, QSTREAM VASCULAR, Replication

Medical, Sapiens Steering Brain Stimulation, SeamVad, Sensible Medical

Innovations, Soft Tissue Regeneration, Specialty Scanners, Vantix, and

Vascular Flow Technologies.

The conference also will feature an outstanding agenda of panels and

networking sessions with industry thought leaders discussing pressing

issues facing the global device industry in 2012 and beyond.

Participating speakers include: Edward Andrle, VP, Business

Development & Strategy, Sorin Group; Arnaud Bernaert, SVP, Corporate

Mergers and Acquisitions, Philips Healthcare; Aris Constantinides,

Investment Director, NBGI Ventures; Bulend Corbacioglu, VP, Business

Development and Licensing, Covidien; Townsend Goddard, Director,

Business Development & Strategic Planning, Stryker; Victor Higgs,

Managing Director, Applied Nanodetectors; Alan O'Connell, Partner,

Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner,

Sofinnova Partners; Stan Rabinovich, VP, Advanced Technology, Edwards

LifeSciences; Thom Rasche, Partner, Earlybird Venture Capital; and

Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director,

ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are

Buyers Looking for in 2012?; Business Challenges Facing Wireless

Health Ventures; and Raising Venture Capital in Europe: The Best of

Times or the Worst of Times? In addition, the two-day program will

feature profile presentations by the following healthcare investment

firms, among others: Forbion, Gilde Healthcare Partners, Fountain

Healthcare Partners, Wellington Partners, Delta Partners, Peppermint

VIP, and Family Office Fund. Partnering software will be available to

all registered attendees prior to the conference so that one-on-one

onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants

in the global medical device sector: start-ups seeking investment or

strategic partnerships, investment firms, VCs, mid-size and large

medical device manufacturers, and service providers. Emerging medtech

companies that would like to apply to present in London should contact

Kayleen Kell at 949-797-7142, or email

k.kell@elsevier.com(mailto:k.kell@elsevier.com).

IN3 Medical Device 360 London will be held at the Millennium

Gloucester Hotel & Conference Centre, London Kensington. Event

co-sponsors to date include Ronald Trahan Associates Inc., Aptiv

Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence

and Scisive Consulting LP. Visit

www.IN3London.com(http://www.in3london.com/) for full conference and

registration details. EBI will be hosting two additional IN3 Medical

Device 360 events in 2012, in Boston and San Francisco; visit

www.elsevierbi.com/conferences(http://www.elsevierbi.com/conferences)

for more information.

About Elsevier Business IntelligenceElsevier Business Intelligence

(EBI), an Elsevier company built on the heritage of F-D-C Reports,

Windhover Information and Medtech Insight, is a global information

supplier providing business intelligence on regulatory, business and

reimbursement issues that are vital to the healthcare industry.

Through a range of products including publications, conferences,

databases and reports, EBI places biopharma and medical device

professionals, and those who focus on these industries, at the

forefront of knowledge, by providing the perfect combination of news

and information together with penetrating insight and analysis. EBI

(www.elsevierbi.com(http://www.elsevierbi.com/)) has offices in the

U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine,

Calif.